Select Equity Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-94,550
Closed -$3.54M 108
2019
Q3
$3.54M Sell
94,550
-399,244
-81% -$15.2M 0.02% 101
2019
Q2
$21.5M Buy
+493,794
New +$21.1M 0.15% 80
2018
Q4
Sell
-521,437
Closed -$35.7M 98
2018
Q3
$35.7M Buy
521,437
+7,603
+1% +$489K 0.26% 66
2018
Q2
$29.4M Buy
513,834
+35,004
+7% +$1.85M 0.24% 67
2018
Q1
$22.1M Buy
+478,830
New +$22.7M 0.18% 70

Other funds holding AVNS

Select Equity Group's AVNS Position: Q4 2019 in Review

Select Equity Group sold out of Avanos Medical (AVNS) in Q4 2019, closing a stake of 94,550 shares — an estimated $3.54M sold.

Select Equity Group first reported a position in AVNS in Q1 2018 and held it in 5 quarters. The position peaked at $35.7M in Q3 2018. 293 funds tracked by Wall St. Rank hold AVNS as of Q4 2019.

  • Select Equity Group reported no remaining Avanos Medical position as of Q4 2019 after selling out during the quarter.
  • Select Equity Group sold 94,550 Avanos Medical shares in Q4 2019, an estimated $3.54M.
  • Select Equity Group first reported a position in Avanos Medical in Q1 2018 and held it in 5 quarters.
  • Select Equity Group's Avanos Medical position peaked at $35.7M in Q3 2018.
  • 293 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2019.

Based on Select Equity Group's 13F filing for Q4 2019, filed 14 Feb 2020.